Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs News Corporation Class A Common Stock (NWSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs News Corporation Class A Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.03 (market cap $3.94B), while News Corporation Class A Common Stock trades at $29.49 (market cap $16.49B). The key difference: News Corporation Class A Common Stock is far larger — about 4.2× Edgewise Therapeutics Inc. Common Stock's market cap, and News Corporation Class A Common Stock pays a 0.67% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and News Corporation Class A Common Stock for 6 Days on average.
| EWTX | NWSA | |
|---|---|---|
Market Cap | $3.94B | $16.49B |
Volume | 810,104 | 2,643,378 |
Sector | Health | Media |
52-Week High | $48.35 | $31.19 |
52-Week Low | $14.89 | $22.40 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $3.48B | $17.31B |
Dividend Yield | — | 0.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
News Corporation (NWSA) trades at $29.63, up 0.85% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $32.20. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $0.35 surpassing the $0.21 expectation. Revenue for 2025 reached $8.45 billion, though net income is projected to decline significantly in 2026. Recent news highlights include the launch of a personalized news AI, 'Hamilton,' and ongoing speculation about a potential re-merger with Fox Corp.
The outlook is cautiously optimistic, supported by strong analyst sentiment and consistent earnings beats. Key opportunities lie in digital real estate and news monetization, while risks include a projected profit margin contraction and broader market volatility. The stock's current valuation, with a P/E of 28.77, suggests growth expectations are already priced in, requiring sustained execution to justify further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About News Corporation Class A Common Stock
News Corporation operates businesses in news and information services, digital real estate, and book publishing. Its brands include Dow Jones, The Wall Street Journal, HarperCollins, Realtor.com, and realestate.com.au.
Read more on NWSA →
